by | Mar 27, 2020

Our editors’ inboxes and comment sections are filled with insightful, sharp, and thought-provoking responses from our readers. So we’ve started a weekly roundup of highlights. Check up on our blog each Friday for more, and send your letters to editor@spectator.org!…

by | Mar 23, 2020

At Thursday’s White House press briefing, President Trump and FDA Commissioner Stephen Hahn announced that the FDA has approved the “compassionate use” of the antimalarial drug chloroquine to treat patients infected with Coronavirus 2019 (“COVID-19”). Under extreme or exigent circumstances,…

by | Mar 18, 2020

Amid the national conversation — a silly, fashionable term except it sounds like the yak-yaks it mostly is — I am reminded of how national leaders used to speak in times of stress. War and total economic ruin, mind, not…

by | Mar 18, 2020

“We know the numerator, but not the denominator.”  — Leading medical researcher, name withheld, discussing the statistical effect of the coronavirus 2019 One of the most difficult problems in assessing the current coronavirus 2019 (hereinafter COVID-19) pandemic is sorting through…

by | Mar 16, 2020

Sickness isn’t the only effect of the coronavirus pandemic. Entire nations’ economies have been shut down, quarantining is common in many places, international travel restrictions are in place, and the bears have shoved aside the bulls on Wall Street. All…

o
Sign Up to receive Our Latest Updates! Register